SA53-OS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SA53-OS, covering 2025-06-05 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]